ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 179 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $359 | -99.8% | 6,661 | +34.3% | 0.02% | -74.2% |
Q4 2018 | $223,000 | -85.5% | 4,961 | -81.8% | 0.06% | -81.4% |
Q3 2018 | $1,543,000 | -23.1% | 27,295 | -9.1% | 0.33% | -20.1% |
Q2 2018 | $2,006,000 | -0.8% | 30,034 | -13.5% | 0.42% | +6.4% |
Q1 2018 | $2,022,000 | +2.8% | 34,726 | +13.8% | 0.39% | -15.5% |
Q4 2017 | $1,966,000 | – | 30,505 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |